A phase II open label trial of pre-operative letrozole in combination with bevacizumab in post-menopausal women with newly diagnosed operable breast cancer
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Bevacizumab (Primary) ; Letrozole (Primary)
- Indications Advanced breast cancer; Carcinoma; Ductal carcinoma; Early breast cancer; HER2 negative breast cancer
- Focus Therapeutic Use
- 14 Dec 2013 Results presented at the 36th Annual San Antonio Breast Cancer Symposium.
- 05 Jan 2010 Actual patient number (28) added as reported by ClinicalTrials.gov.
- 13 Feb 2008 The expected completion date for this trial is now 1 Nov 2006.